Neochem Bio Solutions to Exhibit at China Interdye 2026 for International Growth
Neochem Bio Solutions Limited is set to participate as an exhibitor at the 25th China International Dye Industry, Pigments and Textile Chemicals Exhibition (China Interdye 2026) in Shanghai. This event marks the company's first participation at this globally recognized trade platform for the dye and chemical industry, which attracts numerous international buyers and decision-makers.The company will showcase its specialized Bio-Based Product Line and innovative performance chemicals at the exhibition. These products are designed to enhance customer process efficiency while strictly adhering to global sustainability and ESG standards.
The participation is viewed as a key step in Neochem Bio Solutions Limited's strategic plan to become a global leader in sustainable performance chemicals, aligning with its recent listing and broader growth objectives.
The schedule for the event is detailed below:
| Sr. No. | Particulars of the Event | Date of the Event | Venue |
|---|---|---|---|
| 1 | 25 th China International Dye Industry, Pigments and Textile Chemicals Exhibition | April 15-17, 2026 | Shanghai World Expo Exhibition & Convention Center |
By leveraging this global platform, the company aims to penetrate new international markets, establish relationships with global distributors, and conduct high-level discussions with existing international clients to scale up current business volumes.
NEOCHEM Stock Price Movement
At the close of trade, Neochem Bio Solutions Limited slipped by 0.07% to trade at ₹70. The stock traded within a range of ₹70 to ₹71.9, recording a total volume of 24,000 shares.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.